Experian

Healthy H1 FY20/21 performance; momentum to sustain during Q3 FY20/21

18/11/20 -"Experian performed strongly in Q2 FY20/21 (+5% yoy organic revenue; at top-end of management’s guidance), on the back of the sustained robust momentum in the US mortgage activity and consumer ..."

PDF page sample
Pages
55
Language
English
Published on
18/11/20
Download
You may also be interested by these reports :
07/01/26
Since our last Idea Kicker (10 March 2022), Securitas’ (REDUCE ; Sweden) share price rose by +77%, including an +11% increase over the past twelve ...
07/01/26
The change in the target price reflects the update of the peer group used for comparison-based valuation. We have added Prosegur Compania de ...
05/01/26
Our 2025 EPS estimates have been revised downwards, reflecting a continued negative currency impact (SEK vs € and USD), a one-off charge of ...
03/12/25
Adecco offers levers for improvement, with expected progress on growth and margins across all divisions and additional upside from cost actions and ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO